Authors: Sedlacek, HH

Citation: Hh. Sedlacek, Mechanisms of action of flavopiridol, CR R ONC H, 38(2), 2001, pp. 139-170

Authors: Sedlacek, HH

Citation: Hh. Sedlacek, Pharmacological aspects of targeting cancer gene therapy to endothelial cells, CR R ONC H, 37(3), 2001, pp. 169-215

Authors: Weyel, D Sedlacek, HH Muller, R Brusselbach, S

Citation: D. Weyel et al., Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy, GENE THER, 7(3), 2000, pp. 224-231

Authors: Sedlacek, HH

Citation: Hh. Sedlacek, Kinase inhibitors in cancer therapy - A look ahead, DRUGS, 59(3), 2000, pp. 435-476

Authors: Miller, DW Graulich, W Karges, B Stahl, S Ernst, M Ramaswamy, A Sedlacek, HH Muller, R Adamkiewicz, J

Citation: Dw. Miller et al., Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells, INT J CANC, 81(4), 1999, pp. 568-572